Steward Partners Investment Advisory’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$15.5K Buy
927
+80
+9% +$1.34K ﹤0.01% 3018
2025
Q1
$13K Buy
847
+174
+26% +$2.67K ﹤0.01% 2979
2024
Q4
$14.8K Sell
673
-400
-37% -$8.82K ﹤0.01% 2925
2024
Q3
$19.3K Buy
1,073
+724
+207% +$13K ﹤0.01% 2672
2024
Q2
$5.67K Hold
349
﹤0.01% 3001
2024
Q1
$4.92K Hold
349
﹤0.01% 3050
2023
Q4
$3.64K Hold
349
﹤0.01% 3081
2023
Q3
$3.56K Hold
349
﹤0.01% 2932
2023
Q2
$2.63K Sell
349
-5,900
-94% -$44.4K ﹤0.01% 2975
2023
Q1
$55.3K Buy
6,249
+64
+1% +$566 ﹤0.01% 1826
2022
Q4
$56.4K Hold
6,185
﹤0.01% 1786
2022
Q3
$50K Sell
6,185
-860
-12% -$6.95K ﹤0.01% 1789
2022
Q2
$53K Sell
7,045
-103
-1% -$775 ﹤0.01% 1782
2022
Q1
$67K Hold
7,148
﹤0.01% 1770
2021
Q4
$57K Sell
7,148
-415
-5% -$3.31K ﹤0.01% 1847
2021
Q3
$74K Hold
7,563
﹤0.01% 1686
2021
Q2
$75K Sell
7,563
-2,704
-26% -$26.8K ﹤0.01% 2642
2021
Q1
$118K Sell
10,267
-1,354
-12% -$15.6K ﹤0.01% 1536
2020
Q4
$112K Buy
11,621
+7,423
+177% +$71.5K ﹤0.01% 1318
2020
Q3
$38K Sell
4,198
-16,292
-80% -$147K ﹤0.01% 1626
2020
Q2
$253K Buy
20,490
+14,779
+259% +$182K 0.01% 805
2020
Q1
$51K Buy
5,711
+2,609
+84% +$23.3K ﹤0.01% 1249
2019
Q4
$30K Sell
3,102
-3,539
-53% -$34.2K ﹤0.01% 1628
2019
Q3
$45K Buy
6,641
+3,500
+111% +$23.7K ﹤0.01% 1402
2019
Q2
$28K Buy
+3,141
New +$28K ﹤0.01% 1574
2018
Q4
Sell
-3,517
Closed -$76K 2021
2018
Q3
$76K Buy
3,517
+1,456
+71% +$31.5K ﹤0.01% 1027
2018
Q2
$50K Sell
2,061
-109
-5% -$2.64K ﹤0.01% 1100
2018
Q1
$37K Buy
2,170
+1,320
+155% +$22.5K ﹤0.01% 1110
2017
Q4
$16K Sell
850
-229
-21% -$4.31K ﹤0.01% 1209
2017
Q3
$18K Buy
1,079
+9
+0.8% +$150 ﹤0.01% 968
2017
Q2
$35K Sell
1,070
-302
-22% -$9.88K ﹤0.01% 716
2017
Q1
$44K Buy
1,372
+178
+15% +$5.71K 0.01% 579
2016
Q4
$43K Buy
+1,194
New +$43K 0.02% 341